ExodusPoint Capital Management, LP - RENEO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of RENEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,886
-20.8%
378,977
-31.8%
0.03%
-6.7%
Q2 2023$3,643
+147.8%
555,316
+125.9%
0.03%
+150.0%
Q1 2023$1,470
+355.1%
245,787
+77.3%
0.01%
+140.0%
Q4 2022$323138,6520.01%
Other shareholders
RENEO PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 2,409,220$6,384,0009.38%
Abingworth LLP 2,073,957$5,413,0001.73%
Aisling Capital Management LP 886,075$2,348,0001.68%
NEA Management Company, LLC 4,786,921$12,685,0000.65%
Novo Holdings A/S 3,430,377$9,090,0000.45%
Ikarian Capital, LLC 185,597$491,0000.09%
Rock Springs Capital Management LP 1,143,185$3,029,0000.09%
Newtyn Management, LLC 20,983$56,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 70,000$186,0000.00%
Ergoteles LLC 42,400$112,0000.00%
View complete list of RENEO PHARMACEUTICALS INC shareholders